Applying Mathematical Models for Solid Tumor Growth in the Pharmaceutical Industry

Friday, March 8, 2013 - 1:25pm - 2:25pm
Lind 305
Andrew Stein (Novartis Institute for Biomedical Research )
This talk is divided into three parts. 1) An overview of the Modeling & Simulation group at Novartis and challenges in the drug development industry. 2) An application of a mathematical model for solid tumor growth for assisting with dose selection of a cancer drug. 3) A survey of some open questions in the field of solid tumor growth modeling.

Andy's background is in engineering and mathematics. He earned his BS and MS in Mechanical Engineering from MIT, his PhD in Applied Mathematics from University of Michigan, and completed a postdoctoral fellowship at the Institute for Mathematics and its Applications. Since 2009, he has worked as a biological modeler in the Modeling and Simulation group at Novartis in Cambridge, MA.